Table 1 Encapsulation efficiency (EE) and drug loading efficiency (DLE) of the liposomes.

From: Synchronous inhibition of mTOR and VEGF/NRP1 axis impedes tumor growth and metastasis in renal cancer

Liposome

DOPC (mg/mL)

Cholesterol (mg/mL)

DSPE(PEG)2000-OMe (mg/mL)

TTP (mg/mL)

E (mg/mL)

G (mg/mL)

DLE (%)

EE (%)

L

3.93

0.965

0.140

0.452

–

–

–

–

E-L

3.93

0.965

0.140

0.452

0.4

–

7.29

100

G-L

3.93

0.965

0.140

0.452

–

0.120

2.2

30

EG-L

3.93

0.965

0.140

0.452

0.4

0.120

7.29 (E), 2.2 (G)

100 (E), 30 (G)

  1. Encapsulation efficiency and drug loading efficiency of liposomes containing Everolimus (E-L), EG00229 (G-L), and combination of Everolimus and EG00229 (EG-L), n = 1 measurement per sample